Special Issue "Advances in Nanoparticle-Mediated Drug Delivery"

A special issue of Scientia Pharmaceutica (ISSN 2218-0532).

Deadline for manuscript submissions: 30 June 2019

Special Issue Editors

Guest Editor
Prof. Dr. Murali Mohan Yallapu

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Ave, Room 447, Memphis, TN 38163, USA
E-Mail
Interests: cancer therapy; drug delivery; drug targeting; infectious disease; micelle; nanoparticles; nanotechnology; polymers; targeted therapies; HIV; antibody engineering; antibody–drug conjugates
Guest Editor
Dr. Raghvendra A. Bohara

CURAM, Center for Reasearch in Medical Devices, National University of Ireland Galway, Ireland
E-Mail
Interests: magnetic nanoparticles; cancer medicine; drug targeting; nanotechnology; polymers; targeted therapies
Guest Editor
Dr. Varaprasad Kokkarachedu

Centro de Investigación de Polímeros Avanzados, CIPA, Av.Collao 1202, Edificio Laboratorio CIPA Concepción, Chile
E-Mail
Interests: antibiotics; drug delivery; bionanomaterials for advanced biomedical; energy; environmental; industrial applications

Special Issue Information

Dear Colleagues,

Developments in fundamental knowledge and engineering sciences have helped the field of pharmaceutics. Nanotechnology-based materials are emerging as drug delivery carriers. This Special Issue entitled “Advances in Nanoparticle-Mediated Drug Delivery” from Scientia Pharmaceutica calls for cutting-edge research and review manuscripts dealing with insights of current developments of nanoparticles for targeted drug delivery. The issue will be focused on molecular drug targets, including disease-specific proteins, receptors, enzymes, and genes, which seek to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction, and quality of life.

Prof. Dr. Murali Mohan Yallapu
Dr. Raghvendra A. Bohara
Dr. Varaprasad Kokkarachedu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Scientia Pharmaceutica is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted drug delivery
  • nanoparticles
  • cancer nanomedicine
  • antibiotics
  • polymers

Published Papers

This special issue is now open for submission.
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top